No Data
Hunan Jiudian Pharmaceutical (300705.SZ): Currently, there are 5 regions where Loxoprofen Sodium Gel patches have not been centralized procurement.
Gelonghui, September 9th | Hunan Jiudian Pharmaceuticals (300705.SZ) received a specific investigation from a particular entity on September 9, 2024, regarding the 'progress of the centralized procurement of Losulofen sodium gel patches?' The company stated that as of now, there are 5 regions (Peking, Shanghai, Shandong, Hubei, Fujian) where Losulofen sodium gel patches have not been centrally procured, and 3 regions (Heilongjiang, Anhui, Tibet) where the centralized procurement has been awarded but not implemented.
hunan jiudian pharmaceutical (300705.SZ): The price of lornoxicam sodium gel patch is basically the same in hospitals and outside hospitals (online and offline).
On September 9, 2024, hunan jiudian pharmaceutical (300705.SZ) conducted specific research and responded to the question of how much the price difference between Luosuolofen sodium gel plaster in-hospital and out-hospital is. The company stated that the price of Luosuolofen sodium gel plaster in-hospital and out-hospital (online and offline) is basically the same.
Express News | Northeast Securities: Initiate coverage on Hunan Jiudian Pharmaceutical with a shareholding recommendation.
Express News | Jiudian Pharmaceutical establishes an outpatient company with traditional Chinese medicine clinic services.
Hunan Jiudian Pharmaceutical (300705.SZ): Indobufene tablets have obtained the pharmaceutical registration certificate.
On September 2nd, Jiudian Pharmaceutical (300705.SZ) announced that the company recently received the "Pharmaceutical Registration Certificate" issued by the National Medical Products Administration. The name of the pharmaceutical is Indobufen tablets. Indobufen is a derivative of indolebutyric acid and is a platelet aggregation inhibitor. It mainly exerts its antiplatelet aggregation effect through the following mechanisms: (1) reversibly inhibiting platelet cyclooxygenase, reducing the production of thromboxane B2 (a potent activator of platelet aggregation); (2) inhibiting adenosine diphosphate (ADP), epinephrine, platelet-activating factor (PAF), collagen, and arachidonic acid-induced platelet activation.
Express News | Hunan Jiudian Pharmaceutical: Obtained the registration certificate for Indomethacin Tablets
No Data
No Data